News
CTSI enhances regulatory service structure, promotes staffers
Three members of CTSI’s regulatory support team are filling new roles, as part of structural changes designed to better support investigators in regulatory compliance and adhere to industry best practices.
Sydney Viel, MPH, CPH, has been…
CTSI research on IRB stipulations wins national award
A poster from the Clinical Research Support Center (CRSC) featuring new research on a sampling of IRB stipulations earned a Special Recognition Award from the Society of Clinical Research Associates (SOCRA) at its recent conference.
KL2 scholar finds association between diabetes medication and less severe cases of COVID-19
Published in PLOS ONE, a study led by the University of Minnesota Medical School studied adults with type 2 diabetes who were taking metformin, a commonly prescribed diabetes medication. Researchers found an association with less severe…
Study finds feasibility review service leads to better protocols
The University of Minnesota’s feasibility review service improves the quality of human subjects research protocols and better prepares them for IRB approval, according to
New roles for ODAT team
Sandra Wells, PhD, who has served as Assistant Director of CTSI’s Office of Discovery and Translation (ODAT) since its inception, is stepping into the role of ODAT Director.
CTSI recognizes three University professors for outstanding mentorship
At CTSI's Translational Science Symposium & Poster Session on Sept. 15, CTSI bestowed awards on outstanding research mentors:
Three University-community grantee teams to address local health equity
The Community Engagement to Advance Research and Community Health (CEARCH) office has named three new collaborative teams as recipients of the Community Partnership Grant.
Radical listening to reduce stroke disparities
Black Americans are twice as likely to experience a stroke and face worse outcomes compared to their white peers. But a new project is working to change that.The CTSI-supported study aims to train “stroke champions” who can educate the…
Changing healthcare one neighbor at a time
The social determinants of health — the conditions in which a person lives, learns, works, and plays — account for 80 percent of health outcomes, but they’re almost never used in medical care.
COVID-19 clinical trial from KL2 scholar Carolyn Bramante suggests effective treatment
CTSI KL2 scholar Carolyn Bramante, MD, MPH, led the nation’s first study on whether metformin, fluvoxamine, and ivermectin, or their combinations could serve as possible treatments to prevent ER visits or hospitalization, as well as Long-…